SunOpta Inc. (“SunOpta” or the “Company”) (Nasdaq:STKL) (TSX:SOY), a leading healthy food and beverage company focused on plant-based foods and beverages and fruit-based foods and beverages, today announced financial results for the fourth quarter ended January 2, 2021.
All amounts are expressed in U.S. dollars and results are reported in accordance with U.S. GAAP, except where specifically noted. The Company’s financial results presented below reflect the divestiture of Tradin Organic (Global Ingredients segment) on December 30, 2020, unless otherwise indicated. Tradin Organic has been reported as discontinued operations for the current and prior periods.
Fourth Quarter 2020:
- Revenues of $205.6 million from continuing operations for the fourth quarter of 2020 compared to $186.1 million in the fourth quarter of 2019, an increase of 10.4%.
- Gross margin increased 360 basis points to 15.5% from 11.9% in the prior year.
- Earnings attributable to common shareholders were $70.2 million or $0.78 per share in the fourth quarter of 2020, compared to a loss attributable to common shareholders of $7.6 million or $0.09 per share in the fourth quarter of 2019. This includes earnings from continuing and discontinued operations.
- Adjusted earnings attributable to common shareholders were $1.2 million or $0.01 per diluted common share in the fourth quarter of 2020, compared to a loss of $5.6 million or $0.06 per diluted common share in the fourth quarter of 2019. This includes earnings from continuing and discontinued operations.
- Adjusted EBITDA¹ from continuing operations of $20.6 million, or 10.0% of revenues for the fourth quarter of 2020, versus $11.2 million or 6.0% of revenues in the fourth quarter of 2019.
“The fourth quarter was another strong quarter, capping off a transformational year for SunOpta. We delivered 10.4% revenue growth, 15.5% gross margins and 10.0% EBITDA margins in Q4 reflecting the fundamental strength of the business,” said Joe Ennen, Chief Executive Officer. “The 84% increase in Adjusted EBITDA for the go-forward business during the fourth quarter was on top of a 649% increase a year earlier. We had more Adjusted EBITDA in the fourth quarter of 2020 from continuing operations than in the entire 2019 fiscal year. In the fourth quarter, we again delivered solid growth in both Plant-Based and Fruit-Based segments coupled with substantial margin improvements including a 19.4% gross profit margin in plant-based and a 10.1% gross profit margin in fruit-based. In addition, we significantly strengthened our balance sheet ensuring the flexibility and capacity to continue investing in core growth initiatives. We remain well positioned in favorable, on-trend categories with a strong pipeline of new business opportunities, particularly in plant-based foods and beverages. I am very proud of our execution and the responsiveness of the entire organization to the many challenges we faced throughout 2020 and we are optimistic we will carry this momentum into 2021.”
The table below summarizes the unaudited combined results from continuing operations and discontinued operations for the quarters ended January 2, 2021 and December 28, 2019. The net loss from continuing operations of $34.3 million for the fourth quarter of 2020 included: (i) $11.2 million of facility exit costs (mainly related to the previously announced exit from the Company’s Santa Maria, California, fruit processing facility) severance and asset impairment charges; (ii) a $12.7 million loss on a foreign currency economic hedge of the cash consideration from the sale of Tradin Organic; and (iii) an $8.9 million loss on the retirement of the Company’s 9.5% second lien notes on December 31, 2020. In addition, interest expense of $7.6 million in the fourth quarter of 2020 reflected the Company’s pre-December 30, 2020 capital structure with approximately $425 million of debt versus the approximately $70 million of debt at January 2, 2021. Earnings from discontinued operations for the fourth quarter of 2020 included a pre-tax gain on the sale of Tradin Organic of $111.8 million.
($000s) | Continuing Operations | Discontinued Operations | Combined Operations | |||||||||||||||
Q4 2020 | Q4 2019 | Q4 2020 | Q4 2019 | Q4 2020 | Q4 2019 | |||||||||||||
Revenue | $ | 205,556 | $ | 186,120 | $ | 124,819 | $ | 109,682 | $ | 330,375 | $ | 295,802 | ||||||
Gross Profit | 31,807 | 22,197 | 13,738 | 11,198 | 45,545 | 33,395 | ||||||||||||
Net earnings (loss) | (34,330) | (6,743) | 107,391 | 1,140 | 73,061 | (5,603) | ||||||||||||
Adj. earnings (loss) | (2,456) | (7,125) | 3,635 | 1,528 | 1,179 | (5,597) | ||||||||||||
Adj. EBITDA | 20,570 | 11,162 | 5,969 | 5,208 | 26,539 | 16,370 | ||||||||||||
The following table summarizes revenue growth as reported and as adjusted for the impact of the additional week and commodity price changes in the fourth quarter of 2020:
Revenue
|
Adjusted for
| |||
Plant-Based Foods and Beverages | 11.1% | 6.6% | ||
Fruit-Based Foods and Beverages | 9.6% | 3.9% | ||
Total | 10.4% | 5.4% |
Fourth Quarter 2020 Results from Continuing Operations
Revenues for the fourth quarter of 2020 were $205.6 million, an increase of 10.4% compared to $186.1 million in the fourth quarter of 2019.
The Plant-Based Foods and Beverages segment generated revenues of $118.2 million during the fourth quarter of 2020, an increase of 11.1% compared to $106.4 million in the fourth quarter of 2019. The growth primarily reflects expansion of plant-based beverage and broth offerings for retail customers, and higher volumes of ingredient extraction, partially offset by reduced sales volumes of plant-based beverage products to foodservice customers as a result of COVID-19.
The Fruit-Based Foods and Beverages segment generated revenues of $87.4 million during the fourth quarter of 2020, an increase of 9.6% compared to $79.7 million in the fourth quarter of 2019. The growth primarily reflects increased retail volumes of fruit snacks and frozen fruit, as well as increased pricing for frozen fruit partially offset by lower volume for frozen fruit and fruit preparations to foodservice customers as a result of COVID-19.
Gross profit was $31.8 million for the fourth quarter, an increase of $9.6 million compared to $22.2 million in the prior year period. As a percentage of revenues, gross profit margin was 15.5% in the fourth quarter of 2020 compared to 11.9% in the fourth quarter of 2019, an increase of 360 basis points. The Plant-Based Foods and Beverages segment accounted for $3.1 million of the increase in gross profit, primarily due to higher sales and production volumes of plant-based beverages, broths and plant-based ingredients, coupled with productivity-driven cost savings. The Fruit-Based Foods and Beverages segment increased gross profit by $6.5 million in the quarter, reflecting higher sales, pricing and mix factors, as well as further productivity enhancements.
Segment operating income¹ was $6.8 million, or 3.3% of revenues in the fourth quarter of 2020, compared to an operating loss of $0.5 million, or 0.3% of revenues in the fourth quarter of 2019. The increase in operating income year-over-year was primarily attributable to the $9.6 million increase in gross profit and the benefit from headcount reductions and other cost savings measures taken in 2019, partially offset by higher SG&A primarily driven by employee-related variable compensation and benefit costs.
The Company reported a loss from continuing operations for the fourth quarter of 2020 of $34.3 million, or $0.41 per diluted common share (after dividends on preferred stock). The loss included $11.2 million of facility exit costs, severance and asset impairment charges, a $12.7 million loss on a foreign currency economic hedge of the cash consideration from the sale of Tradin Organic, and an $8.9 million loss on the retirement of the Company’s second lien notes on December 31, 2020. This compares to a loss from continuing operations of $6.7 million, or $0.10 per diluted common share during the fourth quarter of 2019.
Adjusted loss¹ in the fourth quarter of 2020 was $2.5 million or $0.03 per common share, compared to an adjusted loss of $7.1 million or $0.08 per common share in the fourth quarter of 2019.
Adjusted EBITDA¹ was $20.6 million or 10.0% of revenues in the fourth quarter of 2020, compared to $11.2 million or 6.0% of revenues in the fourth quarter of 2019.
Please refer to the discussion and table below under “Non-GAAP Measures”.
Balance Sheet and Cash Flow
At January 2, 2021, SunOpta had total assets of $585.6 million and total debt of $69.7 million compared to total assets of $923.4 million and total debt of $480.0 million a year earlier, primarily reflecting the sale of Tradin Organic and improved operating performance. During the fourth quarter of 2020, cash generated by operating activities of continuing operations was $19.8 million compared to $33.2 million during the fourth quarter of 2019. Investing activities of continuing operations used $11.2 million of cash in the fourth quarter of 2020 versus $7.9 million in the prior year, primarily due to the settlement of the foreign currency contract economically hedging the Tradin Organic cash consideration.
Conference Call
SunOpta plans to host a conference call at 9:00 A.M. Eastern time on Wednesday, March 3, 2021, to discuss the fourth quarter financial results. After opening remarks, there will be a question-and-answer period. Investors interested in listening to a live webcast of the conference call can access a link on SunOpta's website at www.sunopta.com under the "Investors" section or directly here. Investors interested in listening to the live call over the telephone must pre-register for the conference call via a link on SunOpta's website at www.sunopta.com under the "Investors Relations" section or directly at http://www.directeventreg.com/registration/event/9477779. Upon registration, investors will be provided with the dial-in information, passcode and individual ID. Investors will also receive a confirmation email. Investors are encouraged to register at least 15 minutes prior to the scheduled call time and can register earlier at any time to receive the conference details. If you are unable to listen live, the conference call will be archived and can be accessed for approximately 90 days at the Company's website.
¹ See discussion of non-GAAP measures
About SunOpta Inc.
SunOpta Inc. is a leading company specializing in the sourcing, processing and production of organic, natural and non-GMO plant-based and fruit-based food and beverage products.
Forward-Looking Statements
Certain statements included in this press release may be considered "forward-looking statements" within the meaning of the United States Private Securities Litigation Reform Act of 1995 and applicable Canadian securities legislation, which are based on information available to us on the date of this release. These forward-looking statements include, but are not limited to, our belief that investment in plant-based foods and beverages will continue to be a significant driver of revenue and margin growth, and our ability to drive further year-over-year adjusted EBITDA improvement. Generally, forward-looking statements do not relate strictly to historical or current facts and are typically accompanied by words such as “continue”, “expect”, “believe”, “anticipate”, “estimates”, “can”, “will”, “target”, "should", "would", "plans", "becoming", "intend", "confident", "may", "project", "potential", "intention", "might", "predict", “budget”, “forecast” or other similar terms and phrases intended to identify these forward-looking statements. Forward-looking statements are based on information available to the Company on the date of this release and are based on estimates and assumptions made by the Company in light of its experience and its perception of historical trends, current conditions and expected future developments including, but not limited to, the Company’s actual financial results; uninterrupted operations and service levels to our customers during COVID-19; current customer demand for the Company’s products and the additional anticipated demand due to COVID-19; general economic conditions; continued consumer interest in health and wellness; the Company’s ability to maintain product pricing levels; planned facility and operational expansions, closures and divestitures; cost rationalization and product development initiatives; alternative potential uses for the Company’s capital resources; portfolio optimization and productivity efforts; the sustainability of the Company’s sales pipeline; the Company’s expectations regarding commodity pricing, margins and hedging results; improved availability and field prices for fruit; procurement and logistics savings; freight lane cost reductions; yield and throughput enhancements; and labor cost reductions. Whether actual timing and results will agree with expectations and predictions of the Company is subject to many risks and uncertainties including, but not limited to, potential loss of suppliers and customers as well as supply chain, logistics and other disruptions resulting from or related to COVID-19; unexpected issues or delays with the Company’s structural improvements and automation investments; failure or inability to implement portfolio changes, process improvements, go-to-market improvements and process sustainability strategies in a timely manner; changes in the level of capital investment; local and global political and economic conditions; consumer spending patterns and changes in market trends; decreases in customer demand; delayed or unsuccessful product development efforts; potential product recalls; working capital management; availability and pricing of raw materials and supplies; potential covenant breaches under the Company’s credit facilities; and other risks described from time to time under "Risk Factors" in the Company's Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q (available at www.sec.gov). Consequently, all forward-looking statements made herein are qualified by these cautionary statements and there can be no assurance that the actual results or developments anticipated by the Company will be realized. The Company undertakes no obligation to publicly correct or update the forward-looking statements in this document, in other documents, or on its website to reflect future events or circumstances, except as may be required under applicable securities laws.
SunOpta Inc. | ||||||||||||
Consolidated Statements of Operations | ||||||||||||
For the quarters and years ended January 2, 2021 and December 28, 2019 | ||||||||||||
(Unaudited) | ||||||||||||
(All dollar amounts expressed in thousands of U.S. dollars, except per share amounts) | ||||||||||||
Quarter ended | Year ended | |||||||||||
January 2,
|
December 28,
|
January 2,
|
December 28,
| |||||||||
$ | $ | $ | $ | |||||||||
Revenues | 205,556 | 186,120 | 789,213 | 721,596 | ||||||||
Cost of goods sold | 173,749 | 163,923 | 680,136 | 656,093 | ||||||||
Gross profit | 31,807 | 22,197 | 109,077 | 65,503 | ||||||||
Selling, general and administrative expenses | 25,590 | 20,581 | 89,463 | 80,603 | ||||||||
Intangible asset amortization | 2,194 | 2,305 | 8,946 | 9,112 | ||||||||
Other expense (income), net | 22,604 | (653 | ) | 23,393 | (40,639 | ) | ||||||
Foreign exchange gain | (2,790 | ) | (200 | ) | (1,640 | ) | (157 | ) | ||||
Earnings (loss) from continuing operations before the following | (15,791 | ) | 164 | (11,085 | ) | 16,584 | ||||||
Interest expense, net | 7,605 | 8,259 | 30,042 | 32,765 | ||||||||
Loss on retirement of debt | 8,915 | - | 8,915 | - | ||||||||
Loss from continuing operations before income taxes | (32,311 | ) | (8,095 | ) | (50,042 | ) | (16,181 | ) | ||||
Provision for (recovery of) income taxes | 2,019 | (1,352 | ) | (2,740 | ) | (3,101 | ) | |||||
Loss from continuing operations | (34,330 | ) | (6,743 | ) | (47,302 | ) | (13,080 | ) | ||||
Earnings from discontinued operations | 107,391 | 1,140 | 124,820 | 12,322 | ||||||||
Net earnings (loss) | 73,061 | (5,603 | ) | 77,518 | (758 | ) | ||||||
Dividends and accretion on preferred stock | (2,855 | ) | (2,017 | ) | (10,328 | ) | (8,022 | ) | ||||
Earnings (loss) attributable to common shareholders | 70,206 | (7,620 | ) | 67,190 | (8,780 | ) | ||||||
Basic and diluted earnings (loss) per share | ||||||||||||
From continuing operations | (0.41 | ) | (0.10 | ) | (0.65 | ) | (0.24 | ) | ||||
From discontinued operations | 1.19 | 0.01 | 1.40 | 0.14 | ||||||||
Basic and diluted earnings (loss) per share | 0.78 | (0.09 | ) | 0.75 | (0.10 | ) | ||||||
Weighted-average common shares outstanding (000s) | ||||||||||||
Basic | 89,991 | 88,017 | 89,234 | 87,787 | ||||||||
Diluted | 89,991 | 88,017 | 89,234 | 87,787 | ||||||||
SunOpta Inc. | ||||||
Consolidated Balance Sheets | ||||||
As at January 2, 2021 and December 28, 2019 | ||||||
(Unaudited) | ||||||
(All dollar amounts expressed in thousands of U.S. dollars) | ||||||
January 2, 2021 | December 28, 2019 | |||||
$ | $ | |||||
ASSETS | ||||||
Current assets | ||||||
Cash and cash equivalents | 251 | 128 | ||||
Accounts receivable | 72,724 | 71,818 | ||||
Inventories | 147,748 | 153,562 | ||||
Prepaid expenses and other current assets | 21,665 | 20,558 | ||||
Current income taxes recoverable | 6,935 | 7,480 | ||||
Current assets held for sale | - | 236,408 | ||||
Total current assets | 249,323 | 489,954 | ||||
Property, plant and equipment | 158,048 | 159,675 | ||||
Operating lease right-of-use assets | 35,172 | 65,939 | ||||
Goodwill | 3,998 | 3,998 | ||||
Intangible assets | 133,317 | 142,263 | ||||
Other assets | 5,757 | 1,991 | ||||
Long-term assets held for sale | - | 59,539 | ||||
Total assets | 585,615 | 923,359 | ||||
LIABILITIES | ||||||
Current liabilities | ||||||
Bank indebtedness | - | 241,666 | ||||
Accounts payable and accrued liabilities | 118,592 | 89,136 | ||||
Income taxes payable | 1,431 | 356 | ||||
Current portion of long-term debt | 3,478 | 2,492 | ||||
Current portion of operating lease liabilities | 12,750 | 16,084 | ||||
Current portion of long-term liabilities | 200 | 4,286 | ||||
Current liabilities held for sale | - | 51,644 | ||||
Total current liabilities | 136,451 | 405,664 | ||||
Long-term debt | 66,245 | 235,840 | ||||
Operating lease liabilities | 24,582 | 50,657 | ||||
Long-term liabilities | - | 982 | ||||
Deferred income taxes | 25,408 | 9,040 | ||||
Long-term liabilities held for sale | - | 8,743 | ||||
Total liabilities | 252,686 | 710,926 | ||||
Series A Preferred Stock | 87,305 | 82,524 | ||||
Series B Preferred Stock | 27,595 | - | ||||
EQUITY | ||||||
SunOpta Inc. shareholders’ equity | ||||||
Common shares | 326,545 | 318,456 | ||||
Additional paid-in capital | 37,862 | 35,767 | ||||
Accumulated deficit | (147,741 | ) | (214,931 | ) | ||
Accumulated other comprehensive income (loss) | 1,363 | (11,271 | ) | |||
218,029 | 128,021 | |||||
Non-controlling interests | - | 1,888 | ||||
Total equity | 218,029 | 129,909 | ||||
Total equity and liabilities | 585,615 | 923,359 | ||||
SunOpta Inc. | ||||||||||||
Consolidated Statements of Cash Flows | ||||||||||||
For the quarters and years ended January 2, 2021 and December 28, 2019 | ||||||||||||
(Unaudited) | ||||||||||||
(Expressed in thousands of U.S. dollars) | ||||||||||||
Quarter ended | Year ended | |||||||||||
January 2,
|
December 28,
|
January 2,
|
December 28,
| |||||||||
$ | $ | $ | $ | |||||||||
CASH PROVIDED BY (USED IN) | ||||||||||||
Operating activities | ||||||||||||
Net earnings (loss) | 73,061 | (5,603 | ) | 77,518 | (758 | ) | ||||||
Earnings from discontinued operations | 107,391 | 1,140 | 124,820 | 12,322 | ||||||||
Loss from continuing operations | (34,330 | ) | (6,743 | ) | (47,302 | ) | (13,080 | ) | ||||
Items not affecting cash: | ||||||||||||
Depreciation and amortization | 7,415 | 7,774 | 30,308 | 29,266 | ||||||||
Amortization of debt issuance costs | 1,055 | 699 | 4,078 | 2,721 | ||||||||
Deferred income taxes | 2,043 | (230 | ) | 7,553 | 1,075 | |||||||
Stock-based compensation | 4,251 | 1,834 | 11,676 | 6,340 | ||||||||
Loss on foreign currency forward contract | 12,658 | - | 12,658 | - | ||||||||
Impairment of long-lived assets | 7,803 | - | 7,803 | - | ||||||||
Loss on retirement of debt | 8,915 | - | 8,915 | - | ||||||||
Gain on sale of business | - | 242 | - | (44,027 | ) | |||||||
Other | (368 | ) | (59 | ) | (157 | ) | (34 | ) | ||||
Changes in operating assets and liabilities, net of businesses sold | 10,397 | 29,708 | 17,131 | 731 | ||||||||
Net cash provided by (used in) operating activities of continuing operations | 19,839 | 33,225 | 52,663 | (17,008 | ) | |||||||
Net cash provided by operating activities of discontinued operations | 14,282 | 2,967 | 39,033 | 26,817 | ||||||||
Net cash provided by operating activities | 34,121 | 36,192 | 91,696 | 9,809 | ||||||||
Investing activities | ||||||||||||
Purchases of property, plant and equipment | 1,473 | (6,571 | ) | (24,754 | ) | (28,387 | ) | |||||
Cash settlement of foreign currency forward contract | (12,658 | ) | - | (12,658 | ) | - | ||||||
Net proceeds from sale of business | - | (1,348 | ) | - | 63,324 | |||||||
Other | - | - | 41 | - | ||||||||
Net cash provided by (used in) investing activities of continuing operations | (11,185 | ) | (7,919 | ) | (37,371 | ) | 34,937 | |||||
Net cash provided by (used in) investing activities of discontinued operations | 363,496 | (1,286 | ) | 361,889 | (7,718 | ) | ||||||
Net cash provided by (used in) investing activities | 352,311 | (9,205 | ) | 324,518 | 27,219 | |||||||
Financing activities | ||||||||||||
Decrease under revolving credit facilities | (149,518 | ) | (23,641 | ) | (175,990 | ) | (11,290 | ) | ||||
Repayment of long-term debt, including premium paid | (229,729 | ) | (623 | ) | (231,431 | ) | (1,281 | ) | ||||
Borrowings of long-term debt | 5,179 | 413 | 5,179 | 637 | ||||||||
Payment of debt issuance costs | (2,397 | ) | (17 | ) | (4,888 | ) | (412 | ) | ||||
Proceeds on issuance of preferred stock, net of issuance costs | - | - | 26,804 | - | ||||||||
Payment of cash dividends on preferred stock | (2,378 | ) | (1,700 | ) | (4,078 | ) | (6,800 | ) | ||||
Proceeds from the exercise of stock options and employee share purchases | 613 | 166 | 2,048 | 979 | ||||||||
Payment of withholding taxes on stock-based awards | (1,704 | ) | (10 | ) | (4,080 | ) | (394 | ) | ||||
Other | (181 | ) | (5 | ) | (185 | ) | (19 | ) | ||||
Net cash used in financing activities of continuing operations | (380,115 | ) | (25,417 | ) | (386,621 | ) | (18,580 | ) | ||||
Net cash used in financing activities of discontinued operations | (7,216 | ) | (2,297 | ) | (31,063 | ) | (20,183 | ) | ||||
Net cash used in financing activities | (387,331 | ) | (27,714 | ) | (417,684 | ) | (38,763 | ) | ||||
Decrease in cash and cash equivalents during the year | (899 | ) | (727 | ) | (1,470 | ) | (1,735 | ) | ||||
Cash and cash equivalents of discontinued operations: | ||||||||||||
Balance at the beginning of the period | 678 | 1,970 | 1,370 | 2,501 | ||||||||
Foreign exchange gain (loss) on cash and cash equivalents | 212 | 16 | 223 | (47 | ) | |||||||
Less: Balance at the end of period | - | (1,370 | ) | - | (1,370 | ) | ||||||
Cash and cash equivalents - beginning of the period | 260 | 239 | 128 | 779 | ||||||||
Cash and cash equivalents - end of the period | 251 | 128 | 251 | 128 | ||||||||
SunOpta Inc. | ||||||||||||
Segmented Information | ||||||||||||
For the quarters and years ended January 2, 2021 and December 28, 2019 | ||||||||||||
Unaudited | ||||||||||||
(Expressed in thousands of U.S. dollars) | ||||||||||||
Quarter ended | Year ended | |||||||||||
January 2,
|
December 28,
|
January 2,
|
December 28,
| |||||||||
$ | $ | $ | $ | |||||||||
Segment revenues from external customers: | ||||||||||||
Plant-Based Foods and Beverages | 118,179 | 106,371 | 415,164 | 361,398 | ||||||||
Fruit-Based Foods and Beverages | 87,377 | 79,749 | 374,049 | 349,852 | ||||||||
Global Ingredients | - | - | - | 10,346 | ||||||||
Total segment revenues from external customers | 205,556 | 186,120 | 789,213 | 721,596 | ||||||||
Segment gross profit: | ||||||||||||
Plant-Based Foods and Beverages | 22,980 | 19,881 | 80,497 | 58,812 | ||||||||
Fruit-Based Foods and Beverages | 8,827 | 2,316 | 28,580 | 6,499 | ||||||||
Global Ingredients | - | - | - | 192 | ||||||||
Total segment gross profit | 31,807 | 22,197 | 109,077 | 65,503 | ||||||||
Segment operating income (loss): | ||||||||||||
Plant-Based Foods and Beverages | 13,324 | 13,745 | 50,780 | 29,476 | ||||||||
Fruit-Based Foods and Beverages | 1,185 | (4,669 | ) | (7,321 | ) | (26,873 | ) | |||||
Global Ingredients | - | - | - | (187 | ) | |||||||
Corporate Services | (7,696 | ) | (9,565 | ) | (31,151 | ) | (26,471 | ) | ||||
Total segment operating income (loss) | 6,813 | (489 | ) | 12,308 | (24,055 | ) | ||||||
Segment gross profit percentage: | ||||||||||||
Plant-Based Foods and Beverages | 19.4 | % | 18.7 | % | 19.4 | % | 16.3 | % | ||||
Fruit-Based Foods and Beverages | 10.1 | % | 2.9 | % | 7.6 | % | 1.9 | % | ||||
Global Ingredients | - | - | - | 1.9 | % | |||||||
Total segment gross profit percentage | 15.5 | % | 11.9 | % | 13.8 | % | 9.1 | % | ||||
Segment operating income (loss) percentage: | ||||||||||||
Plant-Based Foods and Beverages | 11.3 | % | 12.9 | % | 12.2 | % | 8.2 | % | ||||
Fruit-Based Foods and Beverages | 1.4 | % | -5.9 | % | -2.0 | % | -7.7 | % | ||||
Global Ingredients | - | - | - | -1.8 | % | |||||||
Total segment operating income (loss) percentage | 3.3 | % | -0.3 | % | 1.6 | % | -3.3 | % | ||||
Non-GAAP Measures
In addition to reporting financial results in accordance with U.S. GAAP, the Company provides additional information about its operating results regarding segment operating income, adjusted earnings and adjusted earnings before interest, taxes, depreciation and amortization (“Adjusted EBITDA”), which are not measures in accordance with U.S. GAAP. The Company believes that segment operating income, adjusted earnings and adjusted EBITDA assist investors in comparing performance across reporting periods on a consistent basis by excluding items that are not indicative of its operating performance. The non-GAAP measures of segment operating income, adjusted earnings and adjusted EBITDA should not be considered in isolation or as a substitute for performance measures calculated in accordance with U.S. GAAP.
In order to evaluate its results of operations, the Company uses certain other non-GAAP measures that it believes enhance an investor’s ability to derive meaningful period-over-period comparisons and trends from the results of operations. In particular, the Company evaluates its revenues on a basis that excludes the effects of foreign exchange rates and the impact of acquired or disposed operations. In addition, the Company excludes specific items from its reported results that due to their nature or size, it does not expect to occur as part of its normal business on a regular basis. These items are identified in the tables below. These non-GAAP measures are presented solely to allow investors to more fully assess the Company’s results of operations and should not be considered in isolation of, or as substitutes for an analysis of the Company’s results as reported under U.S. GAAP.
Adjusted Earnings/Loss
When assessing its financial performance, the Company uses an internal measure that excludes losses and gains that it believes are not reflective of normal operations. This information is provided to allow investors to make meaningful comparisons of the Company’s operating performance between periods and to view the Company’s business from the same perspective as the Company’s management. Adjusted earnings/loss and adjusted earnings/loss per diluted share should not be considered in isolation or as a substitute for performance measures calculated in accordance with U.S. GAAP.
The following is a tabular presentation of adjusted earnings/loss and adjusted earnings/loss per diluted share, including a reconciliation from net earnings/loss, which the Company believes to be the most directly comparable U.S. GAAP financial measure. In addition, the Company has prepared this table in a columnar format to present the effects of discontinued operations on its consolidated results for the periods presented. The Company believes this presentation assists investors in assessing the financial performance of its continuing operations.
Continuing Operations | Discontinued Operations | Consolidated | |||||||||||||||
Per Share | Per Share | Per Share | |||||||||||||||
For the quarters ended | $ | $ | $ | $ | $ | $ | |||||||||||
January 2, 2021 | |||||||||||||||||
Net earnings (loss) | (34,330 | ) | 107,391 | 73,061 | |||||||||||||
Dividends and accretion on preferred stock | (2,855 | ) | - | (2,855 | ) | ||||||||||||
Earnings (loss) attributable to common shareholders | (37,185 | ) | (0.41 | ) | 107,391 | 1.19 | 70,206 | 0.78 | |||||||||
Adjusted for: | |||||||||||||||||
Gain on sale of discontinued operations(a) | - | (111,818 | ) | (111,818 | ) | ||||||||||||
Loss on foreign currency forward contract(b) | 12,658 | - | 12,658 | ||||||||||||||
Costs related to Value Creation Plan(c) | 8,548 | (1,331 | ) | 7,217 | |||||||||||||
Loss on retirement of debt(d) | 8,915 | - | 8,915 | ||||||||||||||
Long-lived asset impairments(e) | 2,676 | 771 | 3,447 | ||||||||||||||
Plant expansion costs(f) | 1,546 | - | 1,546 | ||||||||||||||
Other(g) | (732 | ) | (163 | ) | (895 | ) | |||||||||||
Net income tax effect(h) | 1,118 | 8,785 | 9,903 | ||||||||||||||
Adjusted earnings (loss) | (2,456 | ) | (0.03 | ) | 3,635 | 0.04 | 1,179 | 0.01 | |||||||||
December 28, 2019 | |||||||||||||||||
Net earnings (loss) | (6,743 | ) | 1,140 | (5,603 | ) | ||||||||||||
Dividends and accretion on preferred stock | (2,017 | ) | - | (2,017 | ) | ||||||||||||
Earnings (loss) attributable to common shareholders | (8,760 | ) | (0.10 | ) | 1,140 | 0.01 | (7,620 | ) | (0.09 | ) | |||||||
Adjusted for: | |||||||||||||||||
Gain on sale of soy and corn business(i) | 242 | - | 242 | ||||||||||||||
Costs related to Value Creation Plan(j) | 1,042 | 237 | 1,279 | ||||||||||||||
Plant expansion costs(k) | - | 298 | 298 | ||||||||||||||
Other(l) | (1,154 | ) | 112 | (1,042 | ) | ||||||||||||
Net income tax effect(m) | 1,505 | (259 | ) | 1,246 | |||||||||||||
Adjusted earnings (loss) | (7,125 | ) | (0.08 | ) | 1,528 | 0.02 | (5,597 | ) | (0.06 | ) | |||||||
(a) | Reflects the pre-tax gain on sale of Tradin Organic recorded in earnings from discontinued operations. | |
(b) | Reflects a loss on a foreign currency forward contract to economically hedge the cash consideration from the sale of Tradin Organic, which was recorded in other expense. | |
(c) | Reflects long-lived asset impairment and facility closure costs of $6.4 million recorded in other expense; employee termination costs of $1.6 million recorded in SG&A expenses, and the reclassification to earnings from discontinued operations of $1.3 million of professional fees related to the divestiture of Tradin Organic. | |
(d) | Reflects the premium paid ($5.3 million) and write-off of unamortized debt issuance costs ($3.6 million) on the redemption and retirement of our second lien notes, which was recorded in non-operating expenses. | |
(e) | Reflects the write-down of owned and right-of-use assets related to the consolidation of roasting lines at our Crookston, Minnesota, facility, and the write-off of obsolete cocoa processing equipment at Tradin Organic, with was recorded in other expense and earnings from discontinued operations. | |
(f) | Reflects start-up costs related to expansion projects within our plant-based ingredient extraction and beverage operations, which were recorded in cost of goods sold. | |
(g) | Other includes a reversal of previously accrued costs related to the withdrawal of certain consumer-packaged products, which was recorded in other income/expense. | |
(h) | Reflects estimated income tax attributable to the gain on sale of Tradin Organic, together with the tax effect of the other preceding adjustments to earnings based on an overall estimated annual effective tax rate of approximately 30% for 2020. | |
(i) | Reflects the gain on sale of the soy and corn business, which was recorded in other income. | |
(j) | Reflects employee retention and relocation costs of $0.4 million, and professional fees of $0.4 million recorded in SG&A expenses; and employee termination costs of $1.7 million (offset by the reversal of $1.3 million of previously recognized stock-based compensation related to forfeited awards previously granted to terminated employees), which was recorded in other expense and earnings from discontinued operations. | |
(k) | Reflects costs related to the start-up of Tradin Organic’s avocado oil facility in Ethiopia, which were recorded in earnings from discontinued operations. | |
(l) | Other includes gains on the settlement of certain legal matters and a project cancellation, partially offset by losses on disposal of assets, which were recorded in other income/expense and earnings from discontinued operations. | |
(m) | Consolidated reflects the tax effect of the preceding adjustments to earnings and reflects an overall estimated annual effective tax rate of approximately 27% for 2019. |
Continuing Operations | Discontinued Operations | Consolidated | |||||||||||||||
Per Share | Per Share | Per Share | |||||||||||||||
For the years ended | $ | $ | $ | $ | $ | $ | |||||||||||
January 2, 2021 | |||||||||||||||||
Net earnings (loss) | (47,302 | ) | 124,820 | 77,518 | |||||||||||||
Dividends and accretion on preferred stock | (10,328 | ) | - | (10,328 | ) | ||||||||||||
Earnings (loss) attributable to common shareholders | (57,630 | ) | (0.65 | ) | 124,820 | 1.40 | 67,190 | 0.75 | |||||||||
Adjusted for: | |||||||||||||||||
Gain on sale of discontinued operations(a) | - | (111,818 | ) | (111,818 | ) | ||||||||||||
Contingent consideration settlement(b) | - | (2,286 | ) | (2,286 | ) | ||||||||||||
Loss on foreign currency forward contract(c) | 12,658 | - | 12,658 | ||||||||||||||
Costs related to Value Creation Plan(d) | 9,897 | 783 | 10,680 | ||||||||||||||
Loss on retirement of debt(e) | 8,915 | - | 8,915 | ||||||||||||||
Long-lived asset impairments(f) | 2,676 | 771 | 3,447 | ||||||||||||||
Plant expansion costs(g) | 1,883 | - | 1,883 | ||||||||||||||
Other(h) | (189 | ) | (50 | ) | (239 | ) | |||||||||||
Net income tax effect(i) | 255 | 8,809 | 9,064 | ||||||||||||||
Adjusted earnings (loss) | (21,535 | ) | (0.24 | ) | 21,029 | 0.24 | (506 | ) | (0.01 | ) | |||||||
December 28, 2019 | |||||||||||||||||
Net earnings (loss) | (13,080 | ) | 12,322 | (758 | ) | ||||||||||||
Dividends and accretion on preferred stock | (8,022 | ) | - | (8,022 | ) | ||||||||||||
Earnings (loss) attributable to common shareholders | (21,102 | ) | (0.24 | ) | 12,322 | 0.14 | (8,780 | ) | (0.10 | ) | |||||||
Adjusted for: | |||||||||||||||||
Gain on sale of soy and corn business(j) | (44,027 | ) | - | (44,027 | ) | ||||||||||||
Costs related to Value Creation Plan(k) | 9,412 | 237 | 9,649 | ||||||||||||||
Plant expansion costs(l) | 311 | 298 | 609 | ||||||||||||||
Contract manufacturer transition costs(m) | - | 448 | 448 | ||||||||||||||
Product withdrawal and recall costs(n) | 260 | - | 260 | ||||||||||||||
Other(o) | (2,728 | ) | 195 | (2,533 | ) | ||||||||||||
Net income tax effect(p) | 12,394 | (397 | ) | 11,997 | |||||||||||||
Adjusted earnings (loss) | (45,480 | ) | (0.52 | ) | 13,103 | 0.15 | (32,377 | ) | (0.37 | ) | |||||||
(a) | Reflects the pre-tax gain on sale of Tradin Organic recorded in earnings from discontinued operations. | |
(b) | Reflects a gain on the settlement of the remaining earn-out obligation related to a prior acquisition of a premium juice business, which was recorded in earnings from discontinued operations. | |
(c) | Reflects a loss on a foreign currency forward contract to economically hedge the cash consideration from the sale of Tradin Organic, which was recorded in other expense. | |
(d) | Reflects professional fees of $1.0 million and employee retention costs of $0.6 million recorded in SG&A expenses; and long-lived asset impairment and facility closure costs of $6.7 million, and employee termination costs of $3.2 million (offset by the reversal of $0.9 million of previously recognized stock-based compensation related to forfeited awards previously granted to terminated employees), which were recorded in other expense and earnings from discontinued operations. | |
(e) | Reflects the premium paid ($5.3 million) and write-off of unamortized debt issuance costs ($3.6 million) on the redemption and retirement of our second lien notes, which was recorded in non-operating expenses. | |
(f) | Reflects the write-down of owned and right-of-use assets related to the consolidation of roasting lines at our Crookston, Minnesota, facility, and the write-off of obsolete cocoa processing equipment at Tradin Organic, with was recorded in other expense and earnings from discontinued operations. | |
(g) | Reflects start-up costs related to expansion projects within our plant-based ingredient extraction and beverage operations, which were recorded in cost of goods sold. | |
(h) | Other includes a loss of $2.4 million on the settlement of a customer claim related to the recall of certain sunflower products in 2016, net of gains of $2.2 million on the settlement of unrelated matters, and reversal of previously accrued costs related to the withdrawal of certain consumer-packaged products, which was recorded in other income/expense. | |
(i) | Reflects estimated income tax attributable to the gain on sale of Tradin Organic, together with the tax effect of the other preceding adjustments to earnings based on an overall estimated annual effective tax rate of approximately 30% for 2020. | |
(j) | Reflects the gain on sale of the soy and corn business, which was recorded in other income. | |
(k) | Reflects employee retention and relocation costs of $2.2 million, and professional fees of $1.4 million recorded in SG&A expenses; and employee termination costs of $8.6 million (offset by the reversal of $4.1 million of previously recognized stock-based compensation related to forfeited awards previously granted to terminated employees), CEO and CFO recruitment costs of $1.3 million, and facility closure costs of $0.3 million, which was recorded in other expense and earnings from discontinued operations. | |
(l) | Reflects costs related to the expansion of our Allentown, Pennsylvania, plant-based beverage facility and start-up of Tradin Organic’s avocado oil facility in Ethiopia, which were recorded in cost of goods sold and earnings from discontinued operations. | |
(m) | Reflects costs related to the transition of Tradin Organic’s premium juice production activities to new contract manufacturers, which were recorded in earnings from discontinued operations. | |
(n) | Reflects product withdrawal and recall costs that were not eligible for reimbursement under insurance policies or exceeded the limits of those policies, including costs related to the recall of certain sunflower kernel products initiated in 2016, which were recorded in other expense. | |
(o) | Other includes gains on the settlement of certain legal matters and a project cancellation, partially offset by losses on disposal of assets, insurance deductibles, and business development costs, which were recorded in other income/expense and earnings from discontinued operations. | |
(p) | Consolidated reflects the tax effect of the preceding adjustments to earnings and reflects an overall estimated annual effective tax rate of approximately 27% for 2019. |
Segment Operating Income/Loss and Adjusted EBITDA
The Company defines segment operating income/loss as net earnings/loss before income taxes, interest expense and other income/expense items, and adjusted EBITDA as segment operating income/loss plus depreciation, amortization, non-cash stock-based compensation, and other unusual items that affect the comparability of operating performance as identified above in the determination of adjusted earnings/loss. The following is a tabular presentation of segment operating income/loss and adjusted EBITDA, including a reconciliation to net earnings/loss, which the Company believes to be the most directly comparable U.S. GAAP financial measure. In addition, as with adjusted earnings/loss presented above, the Company has prepared this table in a columnar format to present the effects of discontinued operations on its consolidated results for the periods presented. The Company believes this presentation assists investors in assessing the financial performance of its continuing operations.
Continuing Operations | Discontinued Operations | Consolidated | |||||||
For the quarters ended | $ | $ | $ | ||||||
January 2, 2021 | |||||||||
Net earnings (loss) | (34,330 | ) | 107,391 | 73,061 | |||||
Loss attributable to non-controlling interests(a) | - | (259 | ) | (259 | ) | ||||
Gain on sale of discontinued operations(b) | - | (111,818 | ) | (111,818 | ) | ||||
Provision for income taxes | 2,019 | 9,503 | 11,522 | ||||||
Loss on retirement of debt(c) | 8,915 | - | 8,915 | ||||||
Interest expense, net | 7,605 | 613 | 8,218 | ||||||
Other expense, net | 22,604 | 608 | 23,212 | ||||||
Total segment operating income | 6,813 | 6,038 | 12,851 | ||||||
Depreciation and amortization | 7,415 | 1,212 | 8,627 | ||||||
Stock-based compensation(d) | 4,250 | 50 | 4,300 | ||||||
Costs related to Value Creation Plan(e) | 546 | (1,331 | ) | (785 | ) | ||||
Plant expansion costs(f) | 1,546 | - | 1,546 | ||||||
Adjusted EBITDA | 20,570 | 5,969 | 26,539 | ||||||
December 28, 2019 | |||||||||
Net earnings (loss) | (6,743 | ) | 1,140 | (5,603 | ) | ||||
Earnings attributable to non-controlling interests(a) | - | 95 | 95 | ||||||
Provision for (recovery of) income taxes | (1,352 | ) | 1,334 | (18 | ) | ||||
Interest expense, net | 8,259 | 561 | 8,820 | ||||||
Other expense (income), net | (653 | ) | 349 | (304 | ) | ||||
Total segment operating income (loss) | (489 | ) | 3,479 | 2,990 | |||||
Depreciation and amortization | 7,774 | 1,173 | 8,947 | ||||||
Stock-based compensation(d) | 3,093 | 258 | 3,351 | ||||||
Costs related to Value Creation Plan(e) | 784 | - | 784 | ||||||
Plant expansion costs(g) | - | 298 | 298 | ||||||
Adjusted EBITDA | 11,162 | 5,208 | 16,370 | ||||||
(a) | Reflects non-controlling interests in the earnings/loss of certain subsidiaries of Tradin Organic, which is included in earnings from discontinued operations. | |
(b) | Reflects the pre-tax gain on sale of Tradin Organic recorded in earnings from discontinued operations. | |
(c) | Reflects the premium paid ($5.3 million) and write-off of unamortized debt issuance costs ($3.6 million) on the redemption and retirement of our second lien notes, which was recorded in non-operating expenses. | |
(d) | For 2020 and 2019, consolidated stock-based compensation of $4.3 million and $3.4 million, respectively, was recorded in SG&A expenses and earnings from discontinued operations, and the reversal of $1.3 million in 2019 of previously recognized stock-based compensation related to forfeited awards previously granted to terminated employees was recognized in other income. | |
(e) | For 2020, reflects professional fees of $0.5 million (2019 – $0.4 million), employee retention costs of $nil (2019 – $0.4 million) recorded in SG&A expenses, and the reclassification of $1.3 million of professional fees related to the divestiture of Tradin Organic to earnings from discontinued operations. | |
(f) | Reflects start-up costs related to expansion projects within our plant-based ingredient extraction and beverage operations, which were recorded in cost of goods sold. | |
(g) | Reflects costs related to the expansion of our Allentown, Pennsylvania, plant-based beverage facility and start-up of Tradin Organic’s avocado oil facility in Ethiopia, which were recorded in cost of goods sold and earnings from discontinued operations. |
Continuing Operations | Discontinued Operations | Consolidated | |||||||
For the years ended | $ | $ | $ | ||||||
January 2, 2021 | |||||||||
Net earnings (loss) | (47,302 | ) | 124,820 | 77,518 | |||||
Loss attributable to non-controlling interests(a) | - | (301 | ) | (301 | ) | ||||
Gain on sale of discontinued operations(b) | - | (111,818 | ) | (111,818 | ) | ||||
Provision for (recovery of) income taxes | (2,740 | ) | 15,885 | 13,145 | |||||
Loss on retirement of debt(c) | 8,915 | - | 8,915 | ||||||
Interest expense, net | 30,042 | 2,409 | 32,451 | ||||||
Other expense (income), net | 23,393 | (782 | ) | 22,611 | |||||
Total segment operating income | 12,308 | 30,213 | 42,521 | ||||||
Depreciation and amortization | 30,308 | 4,661 | 34,969 | ||||||
Stock-based compensation(d) | 12,570 | 540 | 13,110 | ||||||
Costs related to Value Creation Plan(e) | 1,649 | - | 1,649 | ||||||
Plant expansion costs(f) | 1,883 | - | 1,883 | ||||||
Adjusted EBITDA | 58,718 | 35,414 | 94,132 | ||||||
December 28, 2019 | |||||||||
Net earnings (loss) | (13,080 | ) | 12,322 | (758 | ) | ||||
Earnings attributable to non-controlling interests(a) | - | 154 | 154 | ||||||
Provision for (recovery of) income taxes | (3,101 | ) | 6,322 | 3,221 | |||||
Interest expense, net | 32,765 | 1,912 | 34,677 | ||||||
Other expense (income), net | (40,639 | ) | 591 | (40,048 | ) | ||||
Total segment operating income (loss) | (24,055 | ) | 21,301 | (2,754 | ) | ||||
Depreciation and amortization | 29,266 | 4,686 | 33,952 | ||||||
Stock-based compensation(d) | 10,471 | 1,145 | 11,616 | ||||||
Costs related to Value Creation Plan(e) | 3,556 | - | 3,556 | ||||||
Plant expansion costs(g) | 311 | 298 | 609 | ||||||
Contract manufacturer transition costs(h) | - | 289 | 289 | ||||||
Adjusted EBITDA | 19,549 | 27,719 | 47,268 | ||||||
(a) | Reflects non-controlling interests in the earnings/loss of certain subsidiaries of Tradin Organic, which is included in earnings from discontinued operations. | |
(b) | Reflects the pre-tax gain on sale of Tradin Organic recorded in earnings from discontinued operations. | |
(c) | Reflects the premium paid ($5.3 million) and write-off of unamortized debt issuance costs ($3.6 million) on the redemption and retirement of our second lien notes, which was recorded in non-operating expenses. | |
(d) | For 2020 and 2019, consolidated stock-based compensation of $13.1 million and $11.6 million, respectively, was recorded in SG&A expenses and earnings from discontinued operations, and the reversal of $0.9 million and $4.1 million, respectively, of previously recognized stock-based compensation related to forfeited awards previously granted to terminated employees was recognized in other income. | |
(e) | For 2020, reflects professional fees of $1.0 million (2019 – $1.4 million) and employee retention costs of $0.6 million (2019 – $2.2 million) recorded in SG&A expenses. | |
(f) | Reflects start-up costs related to expansion projects within our plant-based ingredient extraction and beverage operations, which were recorded in cost of goods sold. | |
(g) | Reflects costs related to the expansion of our Allentown, Pennsylvania, plant-based beverage facility and start-up of Tradin Organic’s avocado oil facility in Ethiopia, which were recorded in cost of goods sold and earnings from discontinued operations. | |
(h) | Reflects costs related to the transition of Tradin Organic’s premium juice production activities to new contract manufacturers, which were recorded in earnings from discontinued operations. |
Quarterly Adjusted EBITDA from Continuing Operations
The following table presents quarterly segment operating income/loss and adjusted EBITDA from continuing operations.
Fiscal 2020 | |||||||||||||||
First | Second | Third | Fourth | Full | |||||||||||
Quarter | Quarter | Quarter | Quarter | Year | |||||||||||
$ | $ | $ | $ | $ | |||||||||||
Loss from continuing operations | (3,964 | ) | (5,133 | ) | (3,875 | ) | (34,330 | ) | (47,302 | ) | |||||
Provision for (recovery of) income taxes | (1,497 | ) | (1,821 | ) | (1,441 | ) | 2,019 | (2,740 | ) | ||||||
Loss on retirement of debt | - | - | - | 8,915 | 8,915 | ||||||||||
Interest expense, net | 7,665 | 7,413 | 7,359 | 7,605 | 30,042 | ||||||||||
Other expense (income), net | 555 | (835 | ) | 1,069 | 22,604 | 23,393 | |||||||||
Total segment operating income (loss) | 2,759 | (376 | ) | 3,112 | 6,813 | 12,308 | |||||||||
Depreciation and amortization | 7,725 | 7,655 | 7,513 | 7,415 | 30,308 | ||||||||||
Stock-based compensation | 2,670 | 2,215 | 3,435 | 4,250 | 12,570 | ||||||||||
Costs related to Value Creation Plan | 527 | 456 | 120 | 546 | 1,649 | ||||||||||
Plant expansion costs | - | 92 | 245 | 1,546 | 1,883 | ||||||||||
Adjusted EBITDA | 13,681 | 10,042 | 14,425 | 20,570 | 58,718 | ||||||||||
Fiscal 2019 | |||||||||||||||
First | Second | Third | Fourth | Full | |||||||||||
Quarter | Quarter | Quarter | Quarter | Year | |||||||||||
$ | $ | $ | $ | $ | |||||||||||
Earnings (loss) from continuing operations | 19,757 | (12,380 | ) | (13,714 | ) | (6,743 | ) | (13,080 | ) | ||||||
Provision for (recovery of) income taxes | 7,495 | (3,283 | ) | (5,961 | ) | (1,352 | ) | (3,101 | ) | ||||||
Interest expense, net | 8,520 | 7,697 | 8,289 | 8,259 | 32,765 | ||||||||||
Other expense (income), net | (43,511 | ) | 419 | 3,106 | (653 | ) | (40,639 | ) | |||||||
Total segment operating loss | (7,739 | ) | (7,547 | ) | (8,280 | ) | (489 | ) | (24,055 | ) | |||||
Depreciation and amortization | 7,128 | 7,017 | 7,347 | 7,774 | 29,266 | ||||||||||
Stock-based compensation | 1,632 | 2,702 | 3,044 | 3,093 | 10,471 | ||||||||||
Costs related to Value Creation Plan | 203 | 954 | 1,615 | 784 | 3,556 | ||||||||||
Plant expansion costs | - | 311 | - | - | 311 | ||||||||||
Adjusted EBITDA | 1,224 | 3,437 | 3,726 | 11,162 | 19,549 | ||||||||||
View source version on businesswire.com: https://www.businesswire.com/news/home/20210303005345/en/
Contacts:
ICR
646-277-1260
reed.anderson@icrinc.com
